Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 172

1.
2.

Plasmid DNA vaccine coding eight repeats of gonadotrophin-releasing hormone induced atrophy of prostate in male mice.

Rima UK, Bari ASM, Hossain MZ, Khan MAH.

Prostate Int. 2018 Dec;6(4):151-156. doi: 10.1016/j.prnil.2018.01.001. Epub 2018 Jan 12.

3.

Status of TMPRSS2-ERG fusion in prostate cancer patients from India: correlation with clinico-pathological details and TMPRSS2 Met160Val polymorphism.

Bhanushali A, Rao P, Raman V, Kokate P, Ambekar A, Mandva S, Bhatia S, Das BR.

Prostate Int. 2018 Dec;6(4):145-150. doi: 10.1016/j.prnil.2018.03.004. Epub 2018 Mar 26.

5.

Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4-10 ng/mL and negative digital rectal examination.

Sriplakich S, Lojanapiwat B, Chongruksut W, Phuriyaphan S, Kitirattakarn P, Jun-Ou J, Amantakul A.

Prostate Int. 2018 Dec;6(4):136-139. doi: 10.1016/j.prnil.2018.02.002. Epub 2018 Feb 15.

6.

Naringin sensitizes human prostate cancer cells to paclitaxel therapy.

Erdogan S, Doganlar O, Doganlar ZB, Turkekul K.

Prostate Int. 2018 Dec;6(4):126-135. doi: 10.1016/j.prnil.2017.11.001. Epub 2017 Nov 28.

7.

Dendritic cells pulsed with prostate-specific membrane antigen in metastatic castration-resistant prostate cancer patients: a systematic review and meta-analysis.

Mohammadzadeh M, Shirmohammadi M, Ghojazadeh M, Nikniaz L, Raeisi M, Aghdas SAM.

Prostate Int. 2018 Dec;6(4):119-125. doi: 10.1016/j.prnil.2018.04.001. Epub 2018 Apr 28. Review.

8.

To investigate the correlation between the visual prostate symptom score, the international prostate symptom score, and uroflowmetry parameters in adult Thai males of different educational levels.

Setthawong V, Mahawong P, Pattanachindakun N, Amnattrakul P, Dar FM, Thanavongvibul S.

Prostate Int. 2018 Sep;6(3):115-118. doi: 10.1016/j.prnil.2017.12.001. Epub 2017 Dec 30.

9.

Impact of United States Preventive Services Task Force recommendations on prostate biopsy characteristics and disease presentation at a tertiary-care medical center.

Blair BM, Robyak H, Clark JY, Kaag MG, Lehman EB, Raman JD.

Prostate Int. 2018 Sep;6(3):110-114. doi: 10.1016/j.prnil.2018.03.001. Epub 2018 Mar 9.

10.

Neoadjuvant androgen-deprivation therapy with radical prostatectomy for prostate cancer in association with age and serum testosterone.

Akitake N, Shiota M, Obata H, Takeuchi A, Kashiwagi E, Imada K, Kiyoshima K, Inokuchi J, Tatsugami K, Eto M.

Prostate Int. 2018 Sep;6(3):104-109. doi: 10.1016/j.prnil.2017.10.002. Epub 2017 Nov 21.

11.

Generation of transgenic mouse line with prostate-specific expression of codon-improved Cre recombinase.

Kanayama M, Nakao K, Horie S, Aiba A.

Prostate Int. 2018 Sep;6(3):99-103. doi: 10.1016/j.prnil.2018.04.003. Epub 2018 Apr 27.

12.
13.

Does magnetic resonance imaging-guided biopsy improve prostate cancer detection? A comparison of systematic, cognitive fusion and ultrasound fusion prostate biopsy.

Kam J, Yuminaga Y, Kim R, Aluwihare K, Macneil F, Ouyang R, Ruthven S, Louie-Johnsun M.

Prostate Int. 2018 Sep;6(3):88-93. doi: 10.1016/j.prnil.2017.10.003. Epub 2017 Nov 2.

14.

Prostate irradiation with focal dose escalation to the intraprostatic dominant nodule: a systematic review.

Feutren T, Herrera FG.

Prostate Int. 2018 Sep;6(3):75-87. doi: 10.1016/j.prnil.2018.03.005. Epub 2018 Mar 27. Review.

15.

The effect of prostatic inflammation on clinical outcomes in patients with benign prostate hyperplasia.

Cakir SS, Polat EC, Ozcan L, Besiroglu H, Ötunctemur A, Ozbek E.

Prostate Int. 2018 Jun;6(2):71-74. doi: 10.1016/j.prnil.2017.12.003. Epub 2018 Jan 8.

16.

Late seed migration after prostate brachytherapy with Iod-125 permanent implants.

Maletzki P, Schwab C, Markart P, Engeler D, Schiefer J, Plasswilm L, Schmid HP.

Prostate Int. 2018 Jun;6(2):66-70. doi: 10.1016/j.prnil.2017.09.003. Epub 2017 Sep 30.

17.

General practitioner perception of prostate-specific antigen testing has improved, but more awareness of prostate cancer risk in younger patients is still awaited.

Thurtle DR, Gordon EM, Brierly RD, Conway CJ, McLoughlin J.

Prostate Int. 2018 Jun;6(2):61-65. doi: 10.1016/j.prnil.2017.10.001. Epub 2017 Oct 14.

18.

Kamikihito improves cancer-related fatigue by restoring balance between the sympathetic and parasympathetic nervous systems.

Tamada S, Ebisu K, Yasuda S, Kato M, Ninomiya N, Yamasaki T, Iguchi T, Nakatani T, Watanabe Y.

Prostate Int. 2018 Jun;6(2):55-60. doi: 10.1016/j.prnil.2017.11.002. Epub 2017 Dec 6.

19.

18-Fluoride labeled sodium fluoride positron emission tomography with computer tomography: the impact of pretreatment staging in intermediate- and high-risk prostate cancer.

Harley SJ, Hoffmann R, Bartholomeusz D, Sutherland P, Chatterton B, Kitchener M, Takhar P, Tsopelas C, Fuller A, Wells R, Singh-Rai R, Bolt J.

Prostate Int. 2018 Jun;6(2):50-54. doi: 10.1016/j.prnil.2017.12.002. Epub 2017 Dec 27.

20.

Second primary malignancy after radical prostatectomy in a cohort from the Middle East.

Shahait M, Mukherji D, Hamieh N, Nassif S, Jabbour M, Khauli R, Bulbul M, Abou Kheir W, El Hajj A.

Prostate Int. 2018 Jun;6(2):46-49. doi: 10.1016/j.prnil.2017.09.002. Epub 2017 Sep 30.

Supplemental Content

Loading ...
Support Center